Sign in

CIK 0001776111 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

MBX Biosciences, Inc.

Sign in to watch
Ticker
MBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
3179893100
Business address
11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy President & CEO bought 18,500 shares at $28.41 ($525,663)
  3. 4 Option exercise President & CEO acquired 28,768 shares (option exercise)
  4. 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 35,250 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Option exercise President & CEO acquired 182,859 shares (option exercise)
  12. 4 Open-market buy President & CEO bought 20,000 shares at $13.64 ($272,790)
  13. 4 Open-market buy Director bought 20,000 shares at $13.25 ($264,984)
  14. 4 Open-market buy Director bought 666,666 shares at $18.00 ($11,999,988)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 5 · 99 filings